Ladarixin (DF 2156A free base) is an orally active, allosteric non-competitive and dual CXCR1 and CXCR2 antagonist. Ladarixin can be used for the research of COPD and asthma[1].
Molecular Weight:
375.34
Purity:
99.71
CAS Number:
[849776-05-2]
Formula:
C11H12F3NO6S2
Target:
CXCR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted